Bezpečnosť, Interakcie a Zodpovedné Užívanie

CBD and the Cytochrome P450 Enzyme System

The most clinically significant safety consideration for CBD is its interaction with the cytochrome P450 (CYP450) enzyme system in the liver. CYP450 enzymes — particularly the CYP3A4, CYP2C19, CYP2C9, and CYP2D6 isoforms — metabolise approximately 60% of pharmaceutical drugs. CBD is both a substrate for these enzymes (it is metabolised by them) and an inhibitor (it can slow their activity).

When CBD inhibits CYP450 enzymes, it can increase serum concentrations of other drugs metabolised through the same pathway — the same mechanism behind the famous "grapefruit warning" on many medications. This is not a trivial concern. Drugs with narrow therapeutic windows — where the difference between an effective dose and a toxic dose is small — pose the greatest risk. These include warfarin and other anticoagulants, certain antiepileptic drugs (clobazam, valproate, phenytoin), some antidepressants, and certain chemotherapeutic agents.

The clinical significance of CBD-drug interactions was demonstrated in the trials that led to FDA and EMA approval of Epidiolex/Epidyolex (pharmaceutical-grade CBD for severe childhood epilepsies). Patients taking clobazam alongside CBD experienced elevated clobazam levels requiring dose adjustment. This does not mean people on these medications cannot use CBD — but it absolutely means the decision should involve the prescribing physician, with monitoring and potential dose adjustment.

If you take any prescription medication — particularly anticoagulants, antiepileptics, antidepressants, antipsychotics, immunosuppressants, or chemotherapy — consult your doctor before using CBD. Do not discontinue or reduce prescription medications without medical supervision.

Start Low, Go Slow: The Evidence-Based Dosing Principle

"Start low, go slow" is the universally endorsed approach to CBD dosing, supported by clinical evidence and pharmacokinetic principles. Beginning with a modest dose — typically 10–25mg of CBD per day for adults — and titrating upward gradually over weeks allows your body to acclimate and allows you to identify your minimum effective dose without overshooting into side effects.

Clinical studies have used CBD doses ranging from 25mg to 1500mg per day. For general wellness applications — sleep quality, stress management, post-exercise recovery — the majority of positive outcomes cluster in the 25–75mg per day range. Higher doses are associated with specific therapeutic applications (severe epilepsy, schizophrenia) and should be managed under medical supervision.

The most commonly reported side effects of CBD at high doses are mild and self-limiting: fatigue, diarrhoea, changes in appetite, and — in a small percentage of users at daily doses above 300mg — mild, reversible elevation of liver transaminases (ALT/AST). These effects resolve upon dose reduction or discontinuation. There is no evidence of CBD causing serious liver injury, organ damage, or dependence at any dose studied in clinical trials.

Who Should Avoid CBD or Seek Medical Advice First

The UK Food Standards Agency (FSA) and other regulatory bodies provide specific guidance for vulnerable groups. The FSA currently advises that healthy adults limit CBD intake from food to 10mg per day — a notably conservative recommendation — and advises the following groups to avoid CBD unless under medical direction: children and young people under 18, people taking any medication (prescription or over-the-counter), people trying to conceive, and people who are pregnant or breastfeeding.

EFSA (the European Food Safety Authority) has identified data gaps relating to CBD's effects on the liver, drug interactions, reproductive toxicity, and long-term daily consumption. EFSA has stated that it cannot currently establish the safety of CBD as a novel food — while noting this is not the same as concluding CBD is unsafe. This is why responsible CBD companies avoid making therapeutic claims and direct customers with health conditions to their healthcare providers.

Heffernan's Hemp products are for adults 18+. We recommend that anyone with a medical condition, taking prescription medication, pregnant, breastfeeding, or trying to conceive speak with a qualified healthcare professional before using CBD.

Quality Markers: How to Verify Safety Independently

Product quality is a safety issue. Contaminated or mislabelled CBD products can cause adverse effects unrelated to CBD itself. The single most important quality indicator is a batch-specific Certificate of Analysis (CoA) from an independent ISO/IEC 17025-accredited laboratory. A legitimate CoA should confirm: cannabinoid potency (matching label claims within ±10%), THC compliance (≤0.2% in EU-compliant products), pesticide screening, heavy metals analysis (lead, arsenic, cadmium, mercury), residual solvent detection, and microbial limits (bacteria, yeast, mould).

If a CBD company does not publish batch-specific CoAs or makes them difficult to access, do not buy their products. Period. Price is not a reliability indicator — expensive products can be poor quality, and vice versa. The only reliable quality verification is independent laboratory analysis.

Heffernan's Hemp publishes every Certificate of Analysis. Every production batch is tested at an ISO/IEC 17025-accredited laboratory for cannabinoid potency, terpene profile, THC compliance, pesticides, heavy metals, residual solvents, and microbial limits. Transparency is not optional — it is fundamental to the trust our customers place in us.

Can I take CBD with my prescription medication?

CBD can interact with medications metabolised by CYP450 liver enzymes, potentially increasing their serum concentration. Do not combine CBD with prescription medication without consulting your doctor. Never discontinue or adjust prescription medication without medical supervision.

What are the side effects of CBD?

At typical wellness doses (25–75mg/day), side effects are rare and mild. At high doses, the most commonly reported are fatigue, diarrhoea, appetite changes, and (rarely) mild reversible liver enzyme elevation. CBD is not associated with serious adverse events or dependence.

Is CBD safe during pregnancy?

No. The FSA, EFSA, and other regulatory bodies advise that people who are pregnant or breastfeeding avoid CBD unless under medical direction. There is insufficient safety data for these populations.